How many institutions held ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share in Q4 2022?

2 institutional investors reported ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share for Q4 2022. Use the holders table for investor-level position and value details.

Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO)

Q: What does CUSIP 98978N101 represent in this 13F holders report?

CUSIP 98978N101 is the security identifier for ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share used to aggregate holder disclosures.

CUSIP: 98978N101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock, par value $.001 per share
Shares outstanding: 3,908,612
Total 13F shares: 38,166
Share change: -44,770
Total reported value: $95,415
Price per share: $2.50
Number of holders: 2
Value change: -$129,000
Number of buys: 1
Number of sells: 1

Security key

98978N101

Report period

Q4 2022

Institutions

Top holders

ZIVO full security history Newer quarter: Q1 2023 Previous quarter: Q3 2022 Zivo Bioscience, Inc. SEC filings Zivo Bioscience, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 98978N101

Newer quarter: Q1 2023 Previous quarter: Q3 2022

Recent filing periods:

Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022

Top shareholders of ZIVO - Zivo Bioscience - Common Stock, par value $.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— class O/S missing	281,991	$789,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	— class O/S missing	98,682	$276,000	—	30 Sep 2022	13F
Schechter Investment Advisors, LLC	13F	Company	1.5%	56,770	$159,000	—	30 Sep 2022	13F
CoreCap Advisors, LLC	13F	Company	0.67%	26,166	$73,000	—	30 Sep 2022	13F
Warberg Asset Management LLC	13F	Company	— class O/S missing	84,654	$51,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	— class O/S missing	13,798	$39,000	—	30 Sep 2022	13F
Verdence Capital Advisors LLC	13F	Company	— mixed-class rows	20,000 mixed-class rows	$34,000	—	30 Sep 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	— class O/S missing	11,688	$33,000	—	30 Sep 2022	13F
Ayrton Capital LLC	13F	Company	— class O/S missing	48,850	$29,000	—	30 Sep 2022	13F
CVI Holdings, LLC	13F	Company	— class O/S missing	16,108	$10,000	—	30 Sep 2022	13F
UBS Group AG	13F	Company	— class O/S missing	5,341	$3,000	—	30 Sep 2022	13F
Bartlett & Co. LLC	13F	Company	— class O/S missing	1,000	$3,000	—	30 Sep 2022	13F
BARTLETT & CO. WEALTH MANAGEMENT LLC	13F	Company	— class O/S missing	1,000	$2,800	—	30 Sep 2022	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	— class O/S missing	629	$2,000	—	30 Sep 2022	13F
Tower Research Capital LLC (TRC)	13F	Company	— class O/S missing	291	$1,000	—	30 Sep 2022	13F
Andrew A. Dahl	3/4/5	President / CEO, Director	— class O/S missing	376,000	—	—	21 Oct 2021	3/4/5

Institutional Holders of Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) as of Q4 2022

As of 31 Dec 2022, Zivo Bioscience - Common Stock, par value $.001 per share (ZIVO) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,166 shares. The largest 2 holders included CoreCap Advisors, LLC and Column Capital Advisors, LLC. This page lists 2 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.